Sophia Genetics SA
NASDAQ:SOPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its Industry Average (24.1), the stock would be worth $-24.45 (577% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -5.1 | $5.13 |
0%
|
| Industry Average | 24.1 | $-24.45 |
-577%
|
| Country Average | 19.5 | $-19.83 |
-487%
|
Forward EV/EBIT
Today’s price vs future ebit
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CH |
S
|
Sophia Genetics SA
NASDAQ:SOPH
|
351.3m USD | -5.1 | -4.4 | |
| US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD | 43.2 | 53.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
26.8B USD | 21.2 | 29.5 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
14.7B AUD | 77.8 | 62.8 | |
| JP |
|
M3 Inc
TSE:2413
|
1T JPY | 11.9 | 20.2 | |
| SE |
|
Sectra AB
STO:SECT B
|
52.1B SEK | -134.4 | 97 | |
| US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
4.9B USD | 23.3 | 42.3 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 15.7 | 18.8 | |
| US |
H
|
Heartflow Inc
NASDAQ:HTFL
|
2.8B USD | 0 | 0 | |
| CN |
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
19B CNY | -120.1 | -61.5 | |
| US |
V
|
Vocera Communications Inc
F:V00
|
2.4B EUR | 4 290.1 | -328 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.5 |
| Median | 19.5 |
| 70th Percentile | 25.3 |
| Max | 855.5 |
Other Multiples
Sophia Genetics SA
Glance View
SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.
